Drug resistance in brain diseases and the role of drug efflux transporters
Top Cited Papers
- 15 July 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 6 (8) , 591-602
- https://doi.org/10.1038/nrn1728
Abstract
Resistance to drug treatment is an important hurdle in the therapy of many brain disorders, including brain cancer, epilepsy, schizophrenia, depression and infection of the brain with HIV. Consequently, there is a pressing need to develop new and more effective treatment strategies. Mechanisms of resistance that operate in cancer and infectious diseases might also be relevant in drug-resistant brain disorders. In particular, drug efflux transporters that are expressed at the blood-brain barrier limit the ability of many drugs to access the brain. There is increasing evidence that drug efflux transporters have an important role in drug-resistant brain disorders, and this information should allow more efficacious treatment strategies to be developed.Keywords
This publication has 136 references indexed in Scilit:
- Quantitative in Vivo Microdialysis Study on the Influence of Multidrug Transporters on the Blood-Brain Barrier Passage of Oxcarbazepine: Concomitant Use of Hippocampal Monoamines as Pharmacodynamic Markers for the Anticonvulsant ActivityThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Striking Differences in Individual Anticonvulsant Response to Phenobarbital in Rats with Spontaneous Seizures after Status EpilepticusEpilepsia, 2004
- DNA-microarray analysis of brain cancer: molecular classification for therapyNature Reviews Neuroscience, 2004
- Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanismLife Sciences, 2004
- Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising EnzymesClinical Pharmacokinetics, 2003
- A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depressionThe Pharmacogenomics Journal, 2002
- The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS DisordersClinical Pharmacokinetics, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brainNeuroReport, 2001
- Over-expression of Pglycoprotein in malformations of cortical developmentNeuroReport, 1999